Table 1 Sociodemographic and clinical characteristics of study participants
Variables | No. (%)/Mean ± SD/median (range) |
|---|---|
Gender | |
Female | 132 (44.0) |
Male | 168 (56.0) |
Age (years) | |
18–30 | 18 (6.0) |
31–40 | 39 (13.0) |
41–50 | 54 (18.0) |
51–60 | 72 (24.0) |
> 60 | 117 (39.0) |
Hospital | |
BMCH | 150 (50.0) |
SPH | 150 (50.0) |
Residence | |
Rural | 141 (47.0) |
Urban | 159 (53.0) |
Nationality | |
Pakistani | 267 (89.0) |
Afghan | 33 (11.0) |
Smoking | |
Non-smokers | 177 (59.0) |
Ex-smokers | 24 (8.0) |
Active smokers | 99 (33.0) |
Type of CVD | |
STEMI | 123 (41.0) |
NSTEMI | 33 (11.0) |
CAD | 21 (7.0) |
Cardiomyopathy | 69 (23.0) |
Valvular heart disease | 12 (4.0) |
Heart failure | 24 (8.0) |
Cardiac arrhythmias | 18(6.0) |
Comorbidity | |
No | 120 (40.0) |
Yes | 180 (60.0) |
Number of comorbidities | 1 (0–3) |
0 | 120 (40.0) |
1 | 96 (32.0) |
2 | 66 (22.0) |
3 | 18 (6.0) |
Types of comorbidity | |
Hypertension | 116 |
Diabetes mellitus | 78 |
Anemia | 22 |
Others | 45 |
Length of hospital stay (days) | 4.45 ± 2.40 (2–14) |
≤ 3 | (49.0) |
4–7 | (42.0) |
> 7 | (9.0) |
Number of drugs prescribed | 10.21 ± 2.6 (6–21) |
6–9 | 135 (45.0) |
10–12 | 114 (38.0) |
> 12 | 57 (17.0) |